Immunoglobulin M Oligoclonal Bands: Biomarker of Targetable Inflammation in Primary Progressive Multiple Sclerosis

Villar, Luisa; Casanova, Bonaventura; Ouamara, Nadia; Comabella, Manuel; Jalili, Farzaneh; Leppert, David; de Andres, Clara; Izquierdo, Guillermo; Arroyo, Rafael; Avsar, Timucin; Lapin, Sergey; Johnson, Trina; Montalban, Xavier; Fernandez, Oscar; Alvarez-Lafuente, Roberto; Masterman, Donna; Garcia-Sanchez, Maria; Coret, Francisco; Siva, Aksel; Evdoshenko, Evgeniy; Alvarez-Cermeno, Jose; Bar-Or, Amit

doi:10.1002/ana.24190

Immunoglobulin M Oligoclonal Bands: Biomarker of Targetable Inflammation in Primary Progressive Multiple Sclerosis

Villar L. M., Casanova B., Ouamara N., Comabella M., Jalili F., Leppert D., ...Daha Fazla

ANNALS OF NEUROLOGY, cilt.76, sa.2, ss.231-240, 2014 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 76 Sayı: 2
Basım Tarihi: 2014
Doi Numarası: 10.1002/ana.24190
Dergi Adı: ANNALS OF NEUROLOGY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.231-240
İstanbul Üniversitesi Adresli: Evet

Özet

Objective: To identify a biomarker distinguishing patients who, despite a primary progressive multiple sclerosis (PPMS) clinical course, may nonetheless benefit from immune therapy.